Clinical risk factors and antimicrobial resistance associated with campylobacteriosis in Melbourne, Australia: a retrospective analysis
Antimicrobial resistance in Campylobacter is a global concern. We conducted a single-centre retrospective observational study to investigate antimicrobial resistance in adult patients with Campylobacter gastroenteritis (2020-2023). From our cohort of 331 patients over 3 years, there was 22% ciprofloxacin resistance and 100% susceptibility to erythromycin. Compared to prior literature in Australia, ciprofloxacin resistance has increased over time. Ongoing antimicrobial surveillance, stewardship and review of treatment guidelines are recommended.
Authors
- Katherine A. Bond (ORCID: https://orcid.org/0000-0002-4473-9232)
- Katie Cronin
- Arvind Yerramilli
- Eddie Chan
Institutions
- The Royal Melbourne Hospital (AU)
- The University of Melbourne (AU)
- Peter Doherty Institute (AU)
Publication Details
- Journal
- Internal Medicine Journal
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1111/imj.70310
- Primary Topic
- Salmonella and Campylobacter epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00